Update on Management of Type 2 Diabetes for Cardiologists

Mohammed Qureshi, Emily Gammoh, Jawairia Shakil, Richard Robbins

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


The management of type 2 diabetes mellitus has evolved over the last several years as new antidiabetic agents continue to arrive and change the goals of diabetes care. In 2008, the U.S. Food and Drug Administration mandated that all new antidiabetic agents must demonstrate cardiovascular (CV) safety, which has led to a series of CV outcome trials. In this article, we review the key findings from these CV outcome trials and their impact on diabetes care guidelines.

Original languageEnglish (US)
Pages (from-to)273-280
Number of pages8
JournalMethodist DeBakey cardiovascular journal
Issue number4
StatePublished - Oct 1 2018


  • cardiovascular outcome trials
  • cardiovascular safety
  • diabetes management
  • major adverse cardiac events
  • type 2 diabetes mellitus

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Update on Management of Type 2 Diabetes for Cardiologists'. Together they form a unique fingerprint.

Cite this